ProCE Banner Activity

Management of HCV/HIV Coinfection: New Data From IAS 2015

Conference Coverage
Clinical Thought
My summary of new and noteworthy data on managing HCV/HIV coinfection from IAS 2015.

Released: September 08, 2015

Expiration: September 06, 2016

No longer available for credit.

Share

Faculty

Jürgen K. Rockstroh

Jürgen K. Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
University Hospital Bonn
Bonn, Germany  

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Bristol Myers Squibb

Gilead

Merck Human Health HIV

ViiV Healthcare

Partners

IAS 2015

ProCE Banner

Faculty Disclosure

Primary Author

Jürgen K. Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
University Hospital Bonn
Bonn, Germany  

Jürgen K. Rockstroh, MD, has disclosed that he has received consulting fees from Abbott, AbbVie, Bionor, Bristol-Myers Squibb, Cipla, Gilead Sciences, Janssen, Merck, and ViiV.